In brief
Luigi Mangione, accused of killing United Healthcare CEO Brian Thompson, is in talks with federal prosecutors in New York over a possible plea deal involving two stalking charges that carry a maximum penalty of life in prison. His lawyers are meeting with the Southern District of New York at an upcoming conference to negotiate terms. The case also faces a separate state trial, raising questions about double‑jeopardy protections if a federal conviction is reached. The negotiations are ongoing and may or may not culminate in an agreement, pending court approval.
Mangione’s Attorneys Discuss Possible Plea with Federal Prosecutors
New York, Aug 13 – In a high‑profile criminal case, attorneys representing Luigi Mangione are meeting with the United States Attorney for the Southern District of New York to explore a plea arrangement that could resolve the federal stalking charges alleged to have led to the death of United Healthcare CEO Brian Thompson.
Mangione stands on two federal stalking indictments that could keep him in prison for life if he pleads not guilty and is convicted. The federal prosecutor’s office confirmed that a meeting is scheduled for 11 a.m. on Friday, though details of any potential plea have not yet been released.
According to the US Attorney’s office, discussion of an agreement does not guarantee a final plea, and any deal would require court approval. A plea at the federal level could influence the ongoing New York state trial, which is slated to begin on 8 September, and raise double‑jeopardy concerns under state and federal law.
Mangione has pleaded not guilty in both the federal and state jurisdiction. His attorneys have previously argued that he should not be tried in two courts. The judges, however, have permitted both proceedings to move forward.
If a plea results, the legal strategy might assert that the state cannot prosecute the same facts once the federal case concludes, potentially voiding the state trial. Lawyers and prosecutors remain uncertain about the outcome of the negotiation.
As the case unfolds, the court schedule lists a federal trial set for January 2027 and a state trial commencing in September. News will be updated as new developments emerge.
